glp-1 drug manufacturers Manufacturing: Expansion & Tech Transfer Who are the leading innovators
Description
Considering the short half-life of small molecule oral GLP-1 receptor agonists, perhaps approaches to increase the duration of small molecules with a modified-release formulation may lead to improvements in long-term cardiovascular benefits
How often do GLP-1 side effects actually happen
.png?format=pjpeg&width=1600&quality=75&auto=webp)
10.1016/j.jpsychores.2012.11.013 [DOI] [PubMed] [Google Scholar] 9.Gonzalez JS et al (2008) Depression and diabetes treatment nonadherence: a meta-analysis
Machado-Vieira R, Zanetti MV, Otaduy MC, De Sousa RT, Soeiro-de-Souza MG, Costa AC, et al
It features new microfluidics technology to allow for the low-cost pumping of insulin
Traffic 15 , 13051329 (2014)
